PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Description

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

Conditions

Benign Prostatic Hyperplasia, Localized Prostate Cancer

Study Overview

Study Details

Study overview

The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract symptoms (LUTS) and are diagnosed with localized prostate cancer. Participants will go through baseline and follow up assessments up to 12 months.

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Condition
Benign Prostatic Hyperplasia
Intervention / Treatment

-

Contacts and Locations

La Mesa

San Diego Clinical Trials, La Mesa, California, United States, 91942

Glenview

Endeavour Health (NorthShore University HealthSystem), Glenview, Illinois, United States, 60026

Austin

Urology Austin, PLLC, Austin, Texas, United States, 78745

Alexandria

Potomac Urology Center, Alexandria, Virginia, United States, 22311

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * International Prostate Symptom Score (IPSS) ≥ 8
  • * Gleason Grade Group 1-3
  • * Prostate-specific Antigen (PSA) ≤20ng/mL
  • * Cancer stage less than or equal to T2c
  • * Patients with previous surgical treatment of benign prostatic hyperplasia
  • * MRI evidence of extracapsular extension of cancer
  • * Any severe illness that would prevent complete study participation or confound study results

Ages Eligible for Study

to 80 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

PROCEPT BioRobotics,

Study Record Dates

2026-05